How to Stop Using Mounjaro — and What Actually Happens Next

The biggest myth: stopping suddenly is dangerous

Most people searching this question carry a quiet anxiety that stopping abruptly will cause something to go wrong, a rebound illness, a dangerous hormonal swing, or a sudden uncontrollable appetite spike. That fear is understandable, particularly if you have read about the intense nausea that can accompany the early weeks of treatment and assumed the reverse must be equally dramatic. It is not.

Tirzepatide does not create physical dependence of the kind associated with opioids, benzodiazepines or steroids. There is no recognised withdrawal syndrome. When the injections stop, the medicine clears from the body gradually; the half-life of tirzepatide means concentrations fall over roughly five days, and the clinical effects (slower gastric emptying, reduced appetite, lower blood sugar response) ease off over a similar window rather than snapping off instantly. The how tirzepatide works page has more on the mechanism if that context is useful.

What people sometimes call a "withdrawal" is usually the return of hunger cues that were quieted while the medicine was active. That is a real experience, and it is worth preparing for, but it is physiologically different from withdrawal. If you want to understand exactly what that process involves, the guide to stopping tirzepatide covers the distinction in more detail and what it means for managing the transition well.

What to expect in the weeks after your last dose

The most consistent finding in the clinical literature is that weight regain is common after stopping tirzepatide without continued behavioural support. The SURMOUNT programme, which involved thousands of adults with obesity, showed that participants who stopped tirzepatide after the active treatment period regained a meaningful proportion of the weight they had lost, while those who continued treatment maintained their results. The NHS tirzepatide information page at nhs.uk/medicines/tirzepatide notes this explicitly and advises discussing a plan with your healthcare team before stopping.

Practically, you might notice appetite returning more strongly in the first two to four weeks after your last dose, food feeling less filling than it did on treatment, and blood sugar patterns shifting if you have type 2 diabetes. These are expected physiological responses, not signs that something has gone wrong. The degree varies considerably between individuals, some people find the transition much easier than others, particularly those who have built solid eating habits and regular activity into their routine during treatment.

If you are reviewing the practical side of your current injections, the guide to using tirzepatide covers injection technique and habits that support the medicine's effects, habits that are just as useful when you are planning your exit strategy.

Should you taper the dose, or stop at the dose you are on?

This is the question our prescribers hear most often when patients are thinking about stopping. There is no single answer the evidence has settled on. Some clinicians suggest stepping the dose back down through the titration schedule before stopping; others see no strong clinical rationale for it, since the medicine's clearance is relatively gradual regardless of the dose you stop from. The right approach depends on your reason for stopping, how long you have been on treatment, your current dose, and any conditions being managed alongside weight.

Stopping abruptly from a higher dose (say 12.5 mg or 15 mg) will feel different from stopping from 2.5 mg simply because the pharmacological effect at higher doses is more pronounced. Some people do experience a more noticeable return of GI symptoms or hunger after stopping from a high maintenance dose. A prescriber can weigh this up for your individual situation.

Reasons a prescriber might recommend stopping without a gradual taper include: a confirmed pregnancy (tirzepatide is not recommended during pregnancy), a serious adverse reaction, or a planned surgical procedure, anaesthetists need to know you are or were taking a GLP-1 type medicine. The guide to using Mounjaro covers the surgery and anaesthesia considerations in more detail, and our tips for using Mounjaro can also help you get the most from treatment in the period leading up to any planned stop.

Reasons a planned, gradual approach might make more sense include: managing the return of appetite more gently, or stepping down because your weight and health goals have been met and you and your prescriber are satisfied the conditions that made the medicine appropriate in the first place have changed.

Having the conversation with your prescriber

If you are at the point of thinking about stopping, it is worth noting what prompted that thought: is it side effects that have not settled? Cost? A planned pregnancy? A feeling that you have reached your goal? Each of those leads to a slightly different conversation and a different plan. A prescriber can review your current dose, your progress, and any safety considerations, and help you set a realistic expectation for what comes next, including what the process of stopping Mounjaro looks like in practice and what lifestyle support looks like once the pharmacological appetite suppression is no longer there.

If you are treating or managing type 2 diabetes alongside weight with tirzepatide, stopping without an alternative glucose management plan in place is not advisable; that conversation with your prescriber is especially important. You can read more about the broader treatment landscape on the weight-loss treatment overview page.

If you are considering stopping because of concerns about side effects, it is also worth reading the guidance on the MHRA Yellow Card scheme, where any suspected adverse reactions can be reported. This helps the regulator monitor the safety profile of newer medicines in real-world use.

At nume, every repeat prescription goes through fresh clinical review, a real prescriber reads your case before anything is issued. If you want to talk through stopping, reducing your dose, or what to expect, speak to our prescribers through a free consultation. There is no pressure to continue, and no subscription to unpick. Just an honest clinical conversation.